Oppenheimer Asset Management’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-39,634
Closed -$216K – 1177
2024
Q2
$216K Sell
39,634
-9,759
-20% -$61.5K ﹤0.01% 1059
2024
Q1
$399K Buy
49,393
+14,229
+40% +$126K 0.01% 892
2023
Q4
$350K Sell
35,164
-72,119
-67% -$566K ﹤0.01% 949
2023
Q3
$857K Sell
107,283
-1,698
-2% -$17.1K 0.01% 730
2023
Q2
$1.2M Buy
108,981
+3,774
+4% +$38.9K 0.02% 653
2023
Q1
$1.09M Buy
105,207
+9,485
+10% +$112K 0.02% 665
2022
Q4
$1.05M Sell
95,722
-5,481
-5% -$70.5K 0.02% 671
2022
Q3
$1.57M Buy
101,203
+21,435
+27% +$471K 0.03% 521
2022
Q2
$1.83M Buy
+79,768
New +$1.71M 0.03% 493

Other funds holding DH

Oppenheimer Asset Management's DH Position: Q3 2024 in Review

Oppenheimer Asset Management sold out of Definitive Healthcare (DH) in Q3 2024, closing a stake of 39,634 shares — an estimated $216K sold.

Oppenheimer Asset Management first reported a position in DH in Q2 2022 and held it in 9 quarters. The position peaked at $1.83M in Q2 2022. 125 funds tracked by Wall St. Rank hold DH as of Q3 2024.

  • Oppenheimer Asset Management reported no remaining Definitive Healthcare position as of Q3 2024 after selling out during the quarter.
  • Oppenheimer Asset Management sold 39,634 Definitive Healthcare shares in Q3 2024, an estimated $216K.
  • Oppenheimer Asset Management first reported a position in Definitive Healthcare in Q2 2022 and held it in 9 quarters.
  • Oppenheimer Asset Management's Definitive Healthcare position peaked at $1.83M in Q2 2022.
  • 125 funds tracked by Wall St. Rank held Definitive Healthcare as of Q3 2024.

Based on Oppenheimer Asset Management's 13F filing for Q3 2024, filed 5 Nov 2024.